✦ LIBER ✦

Panitumumab – an effective long-term treatment for patients with metastatic colorectal cancer and wild-type KRAS status

✍ Scribed by Elena Elez; Maria Alsina; Josep Tabernero

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical outcome of panitumumab for meta

✍ Ezzeldin M. Ibrahim; Khaled M. Abouelkhair 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 384 KB

Cost-Effectiveness of Cetuximab, Cetuxim

✍ Hoyle, Martin; Peters, Jaime; Crathorne, Louise; Jones-Hughes, Tracey; Cooper, C 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

Sweeping KRAS generalizations: are we de

✍ Jennifer Zikria; Saravanan Krishnamoorthy; Kristin Kaley; M. Wasif Saif 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 52 KB

Panitumumab combined with irinotecan for

✍ Andre, T.; Blons, H.; Mabro, M.; Chibaudel, B.; Bachet, J.-B.; Tournigand, C.; B 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 275 KB

Economic analysis of bevacizumab, cetuxi

✍ Lawrence, Donna; Maschio, Michael; Leahy, Kevin J.; Yunger, Simon; Easaw, Jacob 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 466 KB

6144 POSTER Phase II Study of Panitumuma

✍ Andre, T.; Chibaudel, B.; Mabro, M.; Bennamoun, M.; Artru, P.; Bachet, J.B.; Had 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB